Pavella Therapeutics Inc. logo

Pavella Therapeutics Inc. (PVLA)

Market Closed
2 Mar, 20:00
NASDAQ (CM) NASDAQ (CM)
$
132. 61
-2.41
-1.78%
$
1.6B Market Cap
- P/E Ratio
- Div Yield
366,889 Volume
- Eps
$ 135.02
Previous Close
Day Range
130.8 141.59
Year Range
18.23 151.18
Want to track PVLA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
PVLA earnings report is expected in 27 days (30 Mar 2026)
Name Time Cons. EPS Eps
Pavella Therapeutics Inc. logo
PVLA Pavella Therapeutics Inc.
30 Mar 2026 (In 3 weeks)
-
-
Pavella Therapeutics Inc. logo
PVLA Pavella Therapeutics Inc.
12 Nov 2025
-
-
Pavella Therapeutics Inc. logo
PVLA Pavella Therapeutics Inc.
11 Nov 2025
-
-
Pavella Therapeutics Inc. logo
PVLA Pavella Therapeutics Inc.
13 Aug 2025
-
-
Pavella Therapeutics Inc. logo
PVLA Pavella Therapeutics Inc.
15 May 2025
-
-

PVLA Earnings Reports FAQ

What is the earnings per share (EPS) for PVLA?

EPS data for PVLA is currently not available, as Pavella Therapeutics Inc has not reported recent earnings.

What is the company's earnings growth rate?

Pavella Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

The next earnings release is expected to be on 2026-03-30, based on the PVLA's typical earnings announcement schedule.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Pavella Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for PVLA at this time, as Pavella Therapeutics Inc has no recent EPS data to calculate it.